2025-08-01 | EffePharm
Biohacking, formerly considered a marginal idea, is now a vital part of the lifestyle and health culture that revolves around longevity. Essentially, biohacking enables people to improve their biological functions through the use of technology, diet, and the utilization of high-end supplements. One of the major aspects of this trend is the substance NAD⁺ (nicotinamide adenine dinucleotide)—a molecule that is necessary for cellular energy, metabolism, and the whole aging process. Along with the progress of science, delivery methods are also evolving, with the introduction of NAD⁺ supplements such as NMN, reduced NMN (NMNH), and liposomal NAD+, which are becoming more popular among health innovators and performance seekers.

NAD⁺ is the most important single coenzyme in more than 500 different enzymatic reactions. It replenishes energy in mitochondria, activates sirtuins that are involved in cell repair, and is necessary for DNA. As time passes, NAD⁺ concentration drops to a very low level, which has been associated with tiredness, memory problems, and a greater risk of certain diseases[1]. The main point in the lifestyle of biohackers is to keep NAD⁺ at an optimal level, as a result of which they can have more years of youth and more resistance to stress. Supplementation is a scientifically proven method to reverse the age-related NAD⁺ decline and keep the cells active.
One major challenge with NAD⁺ supplementation is bioavailability. Orally administered NAD⁺ is often broken down in the digestive system before reaching target tissues. Its fragile structure and poor absorption limit its effectiveness in traditional form.
EffePharm’s solution: LipoAvail™ Liposomal NAD⁺— a new and improved delivery system that wraps NAD⁺ in tiny fat-based shells, thus avoiding decay in the digestive tract and allowing it to get to the blood more quickly and effectively. Major benefits are:
Due to these characteristics, liposomal NAD+ is the best choice for maintaining energy, conditioning, and even aging well.
When direct supplementation of NAD⁺ is limited by absorption barriers, using precursors can be a powerful alternative. Two prominent options are NMN and Reduced NMN (NMNH).
UTHEVER® NMN, developed by EffePharm, is the world’s first clinically validated NMN ingredient with proven benefits for human performance. According to study data:
This makes UTHEVER® NMN a leading choice for brands looking for effective and safe ingredients.
On the other hand, UthPeak® Reduced NMN (NMNH) represents the forefront of NAD⁺ precursor research. As the reduced form of NMN, NMNH offers several advantages:
Together, these precursors provide greater formulation flexibility for customized health solutions.
EffePharm is not just a raw material supplier to the health industry—it is a globally trusted NAD⁺ innovator, and targeting multiple aging pathways (biomarkers). By the full vertical integration from molecule design to final formulation, EffePharm has ensured the control of quality, consistency, and performance to the last detail.
What makes EffePharm unique:
These benefits position EffePharm as a health brand’s first choice for partnership in their journey to provide a sustainable, science-based approach to longevity solutions.
The value of NAD⁺ optimization extends far beyond scientific theory. For active biohackers, NAD⁺ supports measurable improvements in physical and mental performance:
Liposomal NAD+ enables sustained release throughout the day, while NMN and NMNH provide complementary support for users stacking with resveratrol, fasting, or calorie restriction protocols. Whether for longevity, performance, or daily productivity, these tools offer powerful, science-backed benefits.
EffePharm is a leader in the NAD⁺ field that is calling on health brands, supplement developers, and biohacking professionals who value the future to consider the next step in NAD⁺ improvement that is superior to the past. By using scientifically validated delivery methods such as liposomal NAD+, UTHEVER® NMN, and UthPeak® NMNH, we bring to you the products that are made for outcome–ready formulas, trusted worldwide, and created for contemporary health.
References:
[1] Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., Yoshino, J., & Imai, S. I. (2016). Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell metabolism, 24(6), 795– https://doi.org/10.1016/j.cmet.2016.09.013
[2] Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell metabolism, 27(3), 529– https://doi.org/10.1016/j.cmet.2018.02.011
Reference available upon request.
| These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Information on this site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein to diagnose or treat a health problem or disease or prescribe any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular healthcare provider.